Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on February 9th, 2023%
A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis. . . . → Read More: Green Energy Chemical Company Starts-Up, Raises $15M
By Alan, on January 12th, 2023%
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine
By Alan, on January 10th, 2023%
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies
By Alan, on January 5th, 2023%
A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug
By Alan, on November 3rd, 2022%
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round. . . . → Read More: Cancer Detection Start-Up Gains $4M in Seed Funds
By Alan, on October 27th, 2022%
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
By Alan, on October 7th, 2022%
Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test
By Alan, on September 14th, 2022%
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds
By Alan, on July 5th, 2022%
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine
By Alan, on April 28th, 2022%
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|